Composition for anti-inflammation containing 5-adamantan-1-yl-N-(2,4-dihydroxy-benzyl)-2,4-dimethoxy-benzamide
申请人:Amorepacific Corporation
公开号:US09433593B1
公开(公告)日:2016-09-06
5-Adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide disclosed in the present disclosure lacks toxicity and can exhibit superior anti-inflammatory effect. It exhibits superior anti-inflammatory effect, for example, by inhibiting the production of one or more of NO and PGE2, by inhibiting the activity of one or more of the transcription factors NF-κB and AP-1 or by inhibiting proinflammatory cytokines such as IL-1β.
本公开的5-亚当antan-1-基-N-(2,4-二羟基苯基)-2,4-二甲氧基苯酰胺缺乏毒性,并且可以表现出卓越的抗炎作用。例如,它可以通过抑制NO和PGE2的产生,抑制转录因子NF-κB和AP-1中的一个或多个的活性,或抑制促炎细胞因子如IL-1β来表现出卓越的抗炎作用。